Our COO Sabrina Ramkellawan will be discussing considerations when conducting Psychedelic and Cannabinoid research. 

Learning Objectives:

1. Discuss research including different clinical trial phases, study design concepts used in psychedelic research

2. Discuss considerations for conducting research including regulations related to clinical trials with psychedelics and cannabinoids

3. Discuss lack of diverse populations historically in psychedelic research and review strategies for the inclusion of diverse populations 

4. Discuss clinical trial management and commercialization challenges.

Canada Chapter: Considerations for Conducting Psychedelic & Cannabinoid Research - Association of Clinical Research Professionals